Delivery Order SPE2DB22D3016-SPE2DB25FBGC3
- Not listed
- The Defense Logistics Agency (DLA) awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance completion targeted for September 9, 2025. This non-competitive delivery order employs firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml, a specialty pharmaceutical product. This firm fixed price delivery order, with a completion date of September 9, 2025, represents a non-competitive, non-set-aside award for a critical oncology medication supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency has awarded a delivery order valued at $59,802.10 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 IU 15ml pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Darzalex FasPro 1,800mg-30,000 15ml pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at approximately $59.8K to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $17,940.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical supply. The contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary operational hub for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed-price delivery order, valued at $59,802.10, was awarded on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract represents a non-set-aside award issued under competitive procurement, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $71,762.52 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product for military healthcare systems. This firm fixed-price delivery order, awarded on July 28, 2025, carries an ultimate completion date of August 18, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGC3Delivery Order
The Defense Logistics Agency awarded a $17,940.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product on August 25, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as a key supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive federal medical procurement portfolio. The company's contract awards with DLA consistently involve competitively awarded delivery orders with firm fixed pricing across a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies. This award for Darzalex Faspro—a specialty oncology medication—represents a typical transaction within AmerisourceBergen's substantial federal medical supply operations supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 8/25/25 |